Skip to main content

Idarucizumab approved as first agent to reverse a novel oral anticoagulant

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Idarucizumab approved as first agent to reverse a novel oral anticoagulant

User login

Username

Password

Reset your password

Type	Lead	score